← Leaderboards
Ali Guermazi
Boston University (Charles River Campus)
$4,192,828
Attributed
$9,484,735
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.8M · FY2012–20$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$9,484,735 · 3
By mechanism
R01$9,484,735 · 3
Top collaborators
- C Kent Kwoh9 shared
- Jeffrey W Duryea4 shared
- Mark W Grinstaff4 shared
- Brian D Snyder4 shared
Most similar at Boston University (Charles River Campus)
Same institution · by research overlap
- Mark W Grinstaff$24,362,733
- Deepak Kumar$1,641,105
- Eric Kenji Lee$75,324
Others in their field
Top investigators on “Knee”
- David Tobin Felson · Boston University Medical Campus$35,826,206
- Michael C Nevitt · Boston University Medical Campus$30,070,320
- Sharmila Majumdar · University Of California San Francisco$25,779,566
- Jeffrey Neil Katz · Brigham And Women'S Hospital$20,689,637
- Ravinder R Regatte · New York University School Of Medicine$20,101,982
- Stephen P Messier · Wake Forest University$19,405,779
Research focus
KneeDegenerative PolyarthritisDesignBoneImageBaseStructureCartilageFunctional DisorderDisease ProgressionKnee OsteoarthritisAging PopulationFollow-UpDrug DesignLesionDisabilityBone MarrowFda ApprovedJointsComplexFundingDisabling DiseaseCohortEffusion
Grant awards (13)
Tracking Treatable Tissues: Change in qMRI Biomarkers and Future Cartilage Loss$537,510
R01 · FY2020 · AR
Tracking Treatable Tissues: Change in qMRI Biomarkers and Future Cartilage Loss$533,135
R01 · FY2019 · AR
Risk of Incident Knee OA & Clinical Outcomes Based on Imaging Biomarkers$795,990
R01 · FY2018 · AR
Tracking Treatable Tissues: Change in qMRI Biomarkers and Future Cartilage Loss$533,135
R01 · FY2018 · AR
Risk of Incident Knee OA & Clinical Outcomes Based on Imaging Biomarkers$909,946
R01 · FY2017 · AR
Tracking Treatable Tissues: Change in qMRI Biomarkers and Future Cartilage Loss$562,417
R01 · FY2017 · AR
Risk of Incident Knee OA & Clinical Outcomes Based on Imaging Biomarkers$1,556,080
R01 · FY2016 · AR
Risk of Incident Knee OA & Clinical Outcomes Based on Imaging Biomarkers$1,484,912
R01 · FY2015 · AR
Characterizing electrostatic interactions between glycosaminoglycans and cationic$274,341
R01 · FY2015 · GM
Risk of Incident Knee OA & Clinical Outcomes Based on Imaging Biomarkers$1,440,571
R01 · FY2014 · AR
Characterizing electrostatic interactions between glycosaminoglycans and cationic$286,765
R01 · FY2014 · GM
Characterizing electrostatic interactions between glycosaminoglycans and cationic$300,144
R01 · FY2013 · GM
Characterizing electrostatic interactions between glycosaminoglycans and cationic$269,789
R01 · FY2012 · GM